Access cutting-edge postbariatric hypoglycemia treatment through this phase 2 clinical trial at a research site in Morehead City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Morehead City location
Preparing your pre-screening questions…
Access postbariatric hypoglycemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related postbariatric hypoglycemia treatment provided free
Check if you qualify for this postbariatric hypoglycemia clinical trial in Morehead City, NC
No-Cost Study Care
Local to Morehead City
Convenient for NC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
VGX-001-013 (EMERGE) is a Phase 2b study to evaluate an investigational new drug, mizagliflozin, for safety, tolerability and its ability to prevent low blood sugar in patients with post-bariatric hypoglycemia.
Sponsor: Vogenx, Inc.
Yes, this clinical trial (NCT07760961) has an active research site in Morehead City, NC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for postbariatric hypoglycemia treatment options in Morehead City, NC, this clinical trial (NCT07760961) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Morehead City research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced postbariatric hypoglycemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all postbariatric hypoglycemia clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Morehead City — not just this study.
Browse Heart Attack Trials in Morehead City →